| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.075 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.048 | 0.6 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |